A major STM journal publisher of 89 online and print journals, 200 plus open access journals, and related print/online book series, Bentham Science answers the informational needs of the pharmaceutical, biomedical and medical research community. Though access to current volumes is no longer licensed, access to the Bentham's e-Journal archive - 2008 is still provided.

BioMed Central is an STM (Science, Technology and Medicine) publisher of 270 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine and includes broad interest titles, such as BMC Biology and BMC Medicine alongside specialist journals, such as Retrovirology and BMC Genomics. The Max Planck Society is a BMC member and covers article-processing charges for Max Planck authors centrally. Further details are available on the MPDL website.

Frontiers is a community-oriented open-access academic publisher and research network. It was launched in 2007 by scientists from the Swiss Federal Institute of Technology in Lausanne and aims to provide better tools and services to researchers in the Internet age. Since then, Frontiers has become one of the fastest-growing open-access scholarly publishers: over 400,000 high-quality, peer-reviewed articles have been published in about 200 community-driven journals across more than 300 specialty niches in science, medicine and technology. The Max Planck Society covers article-processing charges for Max Planck authors centrally. Further details are available on the MPDL website.

Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Its portfolio consists of two imprints, Future Science and Future Medicine, and the e-Journals from both collections are available to Max Planck users.